Skip to main content
. 2022 Aug 4;13:958368. doi: 10.3389/fimmu.2022.958368

Figure 6.

Figure 6

Construction and validation of a nomogram for predicting the prognosis of BLCA patients. The (A) uniCox and (B) multiCox analyses explored the independent prognostic value of cuproptosis score and multiple clinical factors. (C) Nomogram for predicting the 1-, 3-, and 5-year OS of BLCA patients in TCGA-BLCA cohort. (D) Calibration curves for validating the established nomogram. (E–G) The ROC curves of the nomograms compared for 1-, 3-, and 5-year OS in BLCA patients, respectively. (H–J) The DCA curves of the nomograms compared for 1-, 3-, and 5-year OS in BLCA patients, respectively (***p < 0.001). BLCA, bladder cancer; OS, overall survival; TCGA, The Cancer Genome Atlas; ROC, receiver operating characteristic; DCA, decision curve analysis.